IFEOMA UZOH-ANIGBOGU: Open Payments
NPI 1699079327 · NEW ALBANY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$633 in 26 payments from 5 companies in 2025. Trend: 2023 $870 · 2024 $133 · 2025 $633
Food & beverage: $633
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 9 | $334 |
| ABBVIE INC. | 10 | $174 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| Vanda Pharmaceuticals Inc. | 3 | $52 |
| Novo Nordisk Inc | 1 | $19 |
Products named: Auvelity, VRAYLAR, CAPLYTA, FANAPT.
Industry payments across OH — which companies pay providers there.
